Fundraising FoxViscient Biosciences
San Diego, US · Founded 2016 · 1 known investors
Find your way into Viscient Biosciences
Sign up to find every way you can get introduced to Viscient Biosciences
- Your email: who you already know at Viscient Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Viscient Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Viscient Biosciences develops drugs by studying human 3D tissue models combined with multi-omics analysis to understand disease mechanisms. The company initially focuses on non-alcoholic steatohepatitis (NASH) drug discovery.
Investors · 1
Frequently asked questions
- What does Viscient Biosciences do?
- Viscient Biosciences develops drugs by studying human 3D tissue models combined with multi-omics analysis to understand disease mechanisms. The company initially focuses on non-alcoholic steatohepatitis (NASH) drug discovery.
- Who are Viscient Biosciences's investors?
- Viscient Biosciences's investors include Thynk Capital.
- How much funding has Viscient Biosciences raised?
- Viscient Biosciences has disclosed $1M raised across 1 round.
- Where is Viscient Biosciences headquartered?
- Viscient Biosciences is headquartered in San Diego, US.